Caribou Biosciences · company speakers →
Dr. May will describe novel methods for assessing on- and off-target effects of CRISPR-Cas nucleases and the implications for their design and assessment.
Is this you? Claim this profile →
No public contact links on file.
Sourcing speakers for your event?
Browse the speaker directory →